Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABLIM2 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-08 |
mRNA | ABLIM3 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | AC013461.1 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | ACADVL | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | ACCS | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | ACOT9 | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-11 |
mRNA | ACSL3 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | ACTL6A | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | ACTL6B | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-08 |
mRNA | ACTN1 | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-09 |